Diabeloop and EOFlow announced that they partnered to offer the latter’s EOPatch system with automated insulin delivery in Europe.
This partnership combines the EOPatch, a third-party continuous glucose monitor (CGM) and Diabeloop’s automated insulin delivery algorithm. They all integrate into Diabeloop’s currently under-development smartphone app.
Paris-based Diabeloop said in a news release that they also plan to integrate EOPatch into its DBLG1 system. This would integrate the algorithm into a dedicated handset.
Get the full story at our sister site, Drug Delivery Business News.